GlaxoSmithKline To Pay $92m To Settle Suits Over Patent Gaming
U.K. drug maker GlaxoSmithKline has agreed to pay $92 million to settle a series of antitrust lawsuits targeting its alleged "gaming" of the patents covering antibiotic prescription drug Augmentin....To view the full article, register now.
Already a subscriber? Click here to view full article